(Press-News.org) New research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, particularly in transgender men. The study is published in the Journal of Internal Medicine.
“We saw that transgender men treated with testosterone increased their muscle volume by an average of 21 percent over six years, but also that the amount of abdominal fat increased by 70 percent,” says Tommy Lundberg, docent at the Department of Laboratory Medicine, Karolinska Institutet. “In addition, they had more liver fat and higher levels of ‘bad’ LDL cholesterol, which may increase the risk of cardiovascular disease.”
The researchers followed 17 adult transgender men and 16 transgender women who were prescribed treatment with testosterone and oestrogen, respectively. They used magnetic resonance imaging (MRI) to map body composition and measured metabolic risk factors via blood tests, blood pressure and vascular stiffness. The scans were conducted before the start of hormone therapy, after one year and after five to six years.
The results show that long-term hormone therapy leads to several major changes in both body composition and metabolic risk factors, particularly in transgender men. The changes in fat volumes continued over time, while the greatest changes in muscle mass and strength occurred after just one year of treatment.
“Previous studies in this area have been relatively short-term, up to two years,” explains Tommy Lundberg. “Our results show that it is important to continue monitoring the long-term health effects of hormone therapy in transgender individuals to prevent cardiovascular disease and other health issues.”
In transgender women receiving oestrogen treatment, the changes were not as pronounced. Their muscle volume decreased by an average of seven percent after five years of treatment, whereas muscle strength remained unchanged. The transgender women increased their total fat volume but gained less abdominal fat.
Tissue samples from muscle, fat and skin were also taken as part of the study. The next step is to analyse these tissue samples to understand the interaction between genetic sex and sex hormones. The researchers are investigating, among other things, how hormone treatment affects skeletal muscle gene expression and the mechanisms behind changes in adipose tissue.
“In addition to the health aspects, our research contributes to increased knowledge about reasonable expectations of the masculinising and feminising effects of sex hormone treatment,” says Tommy Lundberg. “However, some of the changes were relatively modest and should raise caution regarding expectations of long-term and large changes in this patient group.”
The research was funded by Region Stockholm, the Thuring Foundation, the 1.6 Million Club, the Centre for Innovative Medicine at Karolinska Institutet, the Swedish Research Council, the Swedish Medical Association, the Novo Nordisk Foundation and the European Foundation for Studies of Diabetes.
Two of the co-authors are employed by AMRA Medical AB. Tommy Lundberg has been compensated for expert opinions on aspects related to skeletal muscle changes in transgender individuals and reimbursed for travelling to give lectures on the same topic.
Publication: “Longitudinal changes in regional fat and muscle composition and cardiometabolic biomarkers over 5 years of hormone therapy in transgender individuals”, Tommy R Lundberg, Andrea Tryfonos, Lisa MJ Eriksson, Helene Rundqvist, Eric Rullman, Mats Holmberg, Salwan Maqdasy, Jennifer Linge, Olof Dahlqvist Leinhard, Stefan Arver, Daniel P Andersson, Anna Wiik, Thomas Gustafsson, Journal of Internal Medicine, online 28 November 2024, doi: 10.1111/joim.20039.
END
Hormone therapy affects the metabolic health of transgender individuals
2024-11-28
ELSE PRESS RELEASES FROM THIS DATE:
Survey of 12 European countries reveals the best and worst for smoke-free homes
2024-11-28
Seven out of ten homes in Europe are smoke-free, according to a major survey published today (Thursday) in ERJ Open Research [1]. However, some countries have come further than others in protecting children and adults from second-hand tobacco smoke in the home.
Greece came out bottom of the 12 countries in the survey, with smoking allowed in more than half of homes. In Romania, Bulgaria and Spain more than four in ten homes allow smoking to take place. England scored the highest out of the 12, with more than eight in ten homes smoke-free, with Ireland, Latvia and Italy following next.
The researchers say that the ...
First new treatment for asthma attacks in 50 years
2024-11-28
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.
The findings, published today in The Lancet Respiratory Medicine, could be “game-changing” for millions of people with asthma and COPD around the world, scientists say.
Asthma attacks and COPD flare-ups (also called exacerbations) can be deadly. Every day in the UK four people with asthma and 85 people with COPD will tragically die. Both conditions are also very common, in the UK someone has an asthma attack every ...
Certain HRT tablets linked to increased heart disease and blood clot risk
2024-11-28
Certain hormone replacement therapy (HRT) tablets containing both oestrogen and progestogen are associated with a higher risk of heart disease and rare but serious blood clots known as venous thromboembolism (VTE) in women around the age of menopause, finds a study from Sweden published by The BMJ today.
Another HRT tablet called tibolone was associated with an increased risk of heart disease, heart attack and stroke, but not blood clots, “highlighting the diverse effects of different hormone combinations and administration methods on the risk of cardiovascular disease,” say the researchers.
HRT is used to relieve menopausal ...
Talking therapy and rehabilitation probably improve long covid symptoms, but effects modest
2024-11-28
Cognitive behavioural therapy (CBT) and a programme of physical and mental rehabilitation probably improve symptoms of long covid, but the effects are modest, finds a review of the latest evidence published by The BMJ today.
Intermittent aerobic exercise also probably improves physical function compared with continuous aerobic exercise. But the researchers found no compelling evidence to support the effectiveness of other interventions, including certain drugs, dietary supplements, inspiratory muscle training, transcranial ...
Ban medical research with links to the fossil fuel industry, say experts
2024-11-28
An investigation published by The BMJ today reveals the extent of fossil fuel industry involvement in medical research, leading to fresh calls for academics and publishing companies to cut ties with companies.
An analysis by journalists Hristio Boytchev, Natalie Widmann and Simon Wörpel found that over the past six years, more than 180 medical articles have acknowledged fossil fuel industry funding, and an additional 1000 articles feature authors who worked for a fossil fuel company or related organisation.
While many studies don’t have an obvious link with fossil fuel industry interests, experts told The BMJ that publishing research ...
Different menopausal hormone treatments pose different risks
2024-11-28
Researchers at Uppsala University have analysed the effects of seven different hormone treatments for menopausal symptoms on the risk of blood clots, stroke and heart attack. The study, which involved around one million women aged between 50 and 58, shows that the risks differ depending on the active substance and how the medicine is taken. Published in the scientific journal BMJ, this is the largest and most comprehensive study of currently prescribed hormonal substances in the world.
“There is concern among women that menopausal hormone therapy increases the risk of cardiovascular disease. This concern is based on older studies conducted more than ...
Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL
2024-11-27
Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene autoleucel (obe-cel), experienced high response rates and most did not need a subsequent stem cell transplant (SCT), according to results from the Phase Ib/II FELIX trial co-led by researchers at The University of Texas MD Anderson Cancer Center.
The findings, published today in the New England Journal of Medicine, ...
Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention
2024-11-27
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor’s visits every three months and – most importantly – consistency.
These daily oral antiretrovirals, more commonly referred to as PrEP (pre-exposure prophylaxis), such as Truvada®, are extremely effective at HIV prevention, but only if they are taken daily as directed. Truvada’s efficacy is greatly compromised when taken inconsistently.
However, results from a recent Gilead-funded clinical trial (Purpose-2) led by physicians at Emory University ...
Discovering the traits of extinct birds
2024-11-27
Looking to inform the conservation of critically endangered bird species, University of Utah biologists completed an analysis identifying traits that correlate with all 216 bird extinctions since 1500.
Species most likely to go extinct sooner were endemic to islands, lacked the ability to fly, had larger bodies and sharply angled wings, and occupied ecologically specific niches, according to research published this month.
While some of these findings mirror previous research on extinct birds, they are the first to correlate bird traits with the timing of ...
Are health care disparities tied to worse outcomes for kids with MS?
2024-11-27
MINNEAPOLIS – People who develop multiple sclerosis (MS) as children and grow up in less advantaged neighborhoods may have a larger volume of inflammation and brain tissue loss on imaging than those who grow up in more advantaged neighborhoods, according to a study published in the November 27, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
MS rarely develops in children. About 5% of people with MS are diagnosed before age 18.
In addition to neighborhood location, worse brain imaging outcomes were also seen ...